Sender Company & Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$121K	Buy	+23,823	New	+$121K	0.03%	183
2024 Q2	–	Sell	-12,934	Closed	-$129K	–	48
2024 Q1	$129K	Buy	+12,934	New	+$129K	0.22%	31